Journal Information
Full text access
Pre-proof, online 4 December 2025
Inside GEMA 5.5: Expert Insights on the Latest Changes in Asthma Management
Visits
46
Carlos Almonacid1,
Corresponding author
caralmsan@gmail.com

Corresponding author: Pulmonology Department. Hospital Universitario Puerta de Hierro Majadahonda - Madrid (Spain), C/ Joaquín Rodrigo, 2. CP: 28220 – Majadahonda, Spain
, Santiago Quirce2, Marina Blanco3, Alfonso del Cubillo4, José Valverde-Molina5, Vicente Plaza6
1 Hospital Puerta de Hierro Majadahonda, Madrid, Spain
2 Hospital Universitario La Paz, Madrid, Spain
3 Servicio de Neumología Complejo Hospitalario Universitario, A Coruña, Spain
4 Hospital de Jerez, Cádiz, Spain
5 Hospital General Universitario Santa Lucía, Cartagena, Spain
6 Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
This item has received
Article information
Abstract

The Spanish Asthma Guideline (GEMA) 5.5 marks a significant conceptual and clinical advance in asthma management across Spanish-speaking healthcare systems. This updated edition incorporates the latest scientific insights into the pathophysiology, diagnosis, phenotyping, and treatment of asthma, while maintaining its practical, evidence-based orientation. A key innovation is the redefinition of therapeutic objectives: treatment is no longer limited to symptom control but is directed toward achieving and sustaining clinical remission, following the principles established by the Spanish REMAS consensus. The guideline also integrates recent evidence supporting the role of biologic therapies in specific inflammatory phenotypes, the implementation of maintenance and reliever therapy (MART) in adolescents, and a more rational approach to bronchodilator use in paediatric exacerbations. Further updates include refined recommendations on stepwise pharmacological strategies, expanded indications for advanced therapies in both adults and children, and updated management of associated conditions such as allergic bronchopulmonary aspergillosis and eosinophilic granulomatosis with polyangiitis. Organisationally, GEMA 5.5 strengthens the role of multidisciplinary asthma units, digital monitoring tools, and adherence-promoting interventions. Overall, GEMA 5.5 represents a paradigm shift toward personalised, remission-oriented asthma care, reinforcing its position as the leading Spanish-language reference for evidence-based clinical practice in respiratory medicine.

Keywords:
Asthma
Spanish
Guideline
GEMA
Full text is only available in PDF
Archivos de Bronconeumología
Article options
Tools